跳至主要内容
临床试验/NCT06251895
NCT06251895已完成不适用

Association of the Systemic Immune-inflammation Index (SII) and Severity of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Mellitus: A Retrospective Cohort Study

Jahra Hospital1 个研究点 分布在 1 个国家目标入组 241 人开始时间: 2021年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
241
试验地点
1
主要终点
SII

研究概览

简要总结

Diabetic ketoacidosis (DKA) is the most serious metabolic complication of type 1 diabetes mellitus (T1DM). Insulin deficiency and inflammation play a role in the pathogenesis of DKA. The investigators aim to assess the systemic immune-inflammation index (SII) as a marker of severity among T1DM patients with DKA and without infection.

详细描述

Diabetic ketoacidosis (DKA) is one of the most severe acute metabolic complications of diabetes mellitus (DM). Therefore, DKA patients require prompt treatment and any delay in identifying severe DKA cases can lead to worse outcomes. DKA provokes a systemic inflammatory response through increased levels of various cytokines such as interleukin (IL)-8, IL-6, IL-10, tumor necrosis factor-alpha (TNF-α), and IL-1B. This will lead to cellular activation, cellular adhesion, increased oxidative stress, and endothelial damage, possibly contributing to complications. Consequently, surrogate markers of inflammation and immune status may help in the early identification of patients with severe DKA.

The systemic immune-inflammation index (SII) had a better prognostic value compared to NLR and PLR among cancer patients. Recently, studies have suggested a link between SII and increased risk of atherosclerotic cardiovascular disease (ASCVD), hepatic steatosis, and worse outcomes among hypertensive patients and patients with stroke.

Therefore, the investigators aim to examine SII as a marker of severity in T1DM patients with DKA in an uninfected state.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of T1DM
  • Hospitalization because of DKA
  • Age ≥ 12 years.

排除标准

  • Diagnosis of T2DM
  • Diagnosis of Infection
  • Renal impairment
  • Malignancy
  • ASCVD (atherosclerotic cardiovascular disease)
  • History of any medical condition or medications that can change CBC parameters or cause metabolic acidosis
  • Pregnancy

结局指标

主要结局

SII

时间窗: Day 1 (baseline)

SII = (neutrophil × platelet) / lymphocyte.

次要结局

  • ICU admission(Hospital stay up to one week)
  • readmission(within 90 days)

研究者

发起方
Jahra Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Aon

Principal Investigator

Jahra Hospital

研究点 (1)

Loading locations...

相似试验